Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,000
Closed -$2.22M 6140
2023
Q2
$2.22M Hold
30,000
﹤0.01% 3383
2023
Q1
$2.37M Buy
30,000
+25,000
+500% +$1.8M ﹤0.01% 3274
2022
Q4
$342K Buy
+5,000
New +$318K ﹤0.01% 5001
2021
Q1
Sell
-5,000
Closed -$271K 5937
2020
Q4
$271K Buy
+5,000
New +$240K ﹤0.01% 4615

Other funds holding BRKR

Israel Englander's BRKR Position: Q2 2026 in Review

Israel Englander sold out of Bruker (BRKR) in Q2 2026, closing a stake of 1,485,089 shares — an estimated $53.6M sold.

Israel Englander first reported a position in BRKR in Q2 2013 and held it in 51 quarters. The position peaked at $104M in Q4 2023. 414 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Israel Englander reported no remaining Bruker position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 1,485,089 Bruker shares in Q2 2026, an estimated $53.6M.
  • Israel Englander first reported a position in Bruker in Q2 2013 and held it in 51 quarters.
  • Israel Englander's Bruker position peaked at $104M in Q4 2023.
  • 414 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.